H.R. 8663 · 118TH CONGRESSIntroduced · Dec 23, 2024
DETECT Fentanyl and Xylazine Act of 2024
Take Action
Introduced
House
Senate
Resolving Differences
President
Became Law
Summary
No summary available yet.
No summary available yet.
On Motion to Suspend the Rules and Concur in the Senate Amendments
On Motion to Suspend the Rules and Concur in the Senate Amendments
The House of Representatives voted 404-1 to concur with Senate amendments to H.R. 8663, the DETECT Fentanyl and Xylazine Act of 2024. This vote was held under a suspension of the rules, a procedure typically reserved for non-controversial legislation that requires a two-thirds majority to pass. The bill focuses on enhancing the federal government's ability to identify and intercept fentanyl and xylazine, a potent animal tranquilizer often mixed with opioids. The result represents a significant bipartisan consensus, with nearly every present member of both parties voting in favor. By concurring with the Senate's amendments, the House has finalized the legislative language for this bill. This action effectively clears the measure for the final stage of the lawmaking process. Because both chambers of Congress have now agreed on the exact same version of the bill, it will be sent to the President's desk to be signed into law. Once signed, the act will authorize new resources or protocols for law enforcement and health officials to combat the ongoing synthetic drug crisis.